Evotec SE (EVO)
1.59
-0.08
(-4.79%)
USD |
NASDAQ |
Sep 18, 16:00
1.59
0.00 (0.00%)
After-Hours: 20:00
Evotec Enterprise Value : 604.90M for Sept. 17, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 17, 2026 | 604.90M |
| September 16, 2026 | 590.70M |
| September 15, 2026 | 590.70M |
| September 14, 2026 | 608.45M |
| September 11, 2026 | 626.21M |
| September 10, 2026 | 640.42M |
| September 09, 2026 | 654.63M |
| September 08, 2026 | 658.18M |
| September 04, 2026 | 672.39M |
| September 03, 2026 | 686.59M |
| September 02, 2026 | 686.59M |
| September 01, 2026 | 651.08M |
| August 31, 2026 | 679.49M |
| August 28, 2026 | 690.15M |
| August 27, 2026 | 711.46M |
| August 26, 2026 | 704.35M |
| August 25, 2026 | 683.04M |
| August 24, 2026 | 683.04M |
| August 21, 2026 | 697.25M |
| August 20, 2026 | 707.90M |
| August 19, 2026 | 715.01M |
| August 18, 2026 | 690.15M |
| August 17, 2026 | 707.90M |
| August 14, 2026 | 707.90M |
| August 13, 2026 | 729.22M |
| Date | Value |
|---|---|
| August 12, 2026 | 789.60M |
| August 11, 2026 | 757.63M |
| August 10, 2026 | 750.53M |
| August 07, 2026 | 722.11M |
| August 06, 2026 | 704.35M |
| August 05, 2026 | 715.01M |
| August 04, 2026 | 704.35M |
| August 03, 2026 | 700.80M |
| July 31, 2026 | 690.15M |
| July 30, 2026 | 697.25M |
| July 29, 2026 | 697.25M |
| July 28, 2026 | 707.90M |
| July 27, 2026 | 693.70M |
| July 24, 2026 | 700.80M |
| July 23, 2026 | 715.01M |
| July 22, 2026 | 704.35M |
| July 21, 2026 | 722.11M |
| July 20, 2026 | 715.01M |
| July 17, 2026 | 707.90M |
| July 16, 2026 | 711.46M |
| July 15, 2026 | 725.66M |
| July 14, 2026 | 771.84M |
| July 13, 2026 | 874.84M |
| July 10, 2026 | 1.001B |
| July 09, 2026 | 1.020B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Sartorius AG | 15.55B |
| SCHOTT Pharma AG & Co. KGaA | 3.920B |
| Agilent Technologies, Inc. | 46.27B |
| Bio-Rad Laboratories, Inc. | 9.975B |
| Bruker Corp. | 11.26B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -54.24M |
| Revenue (Quarterly) | 166.82M |
| Total Expenses (Quarterly) | 221.06M |
| EPS Diluted (Quarterly) | -0.1526 |
| Gross Profit Margin (Quarterly) | -1.10% |
| Profit Margin (Quarterly) | -32.51% |
| Earnings Yield | -40.76% |
| Normalized Earnings Yield | -30.08 |